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Abstract Leukotrienes are important lipid mediators implicated
in the regulation of various cellular processes and in disease
states as well as homeostasis. Regulation of leukotriene
biosynthesis is therefore of considerable interest. Although the
levels of expression and catalytic activity of leukotriene-forming
proteins have long been recognized as important determinants of
leukotriene biosynthesis, it has recently become apparent that
their intracellular compartmentalization also affects the inte-
grated output of this biosynthetic pathway. In this minireview, we
focus on the unexpected discovery that the nucleus is the key
intracellular site for leukotriene biosynthesis and discuss the
mechanisms that regulate protein localization and the potential
implications of these findings. ß 2001 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Leukotrienes (LTs) are potent mediators of in£ammation
best known for their role in the pathogenesis of asthma [1].
It is now recognized that they modulate a myriad of cellular
processes and participate not only in various in£ammatory
disease states [2] but also in homeostasis [3]. These lipid me-
diators are synthesized predominantly by leukocytes via the 5-
lipoxygenase (5-LO) pathway of arachidonic acid metabolism
(see Fig. 1). In view of the importance of LT actions, sub-
stantial e¡ort has been directed at understanding the biochem-
ical, molecular, and cellular aspects of this biosynthetic path-
way. As might be expected, each of the key enzymes involved
in LT synthesis is subject to regulation at the levels of protein
expression and catalytic activity. Only in the last decade has
research focused on the intracellular site(s) of LT synthesis.
These studies have revealed an unexpected critical role for the
cell nucleus as a site at which 5-LO and other LT biosynthetic
enzymes are localized. This minireview will focus on the cur-
rent understanding of the compartmentalization of LT bio-
synthesis. The localization of 5-LO in resting and activated
leukocytes under di¡erent physiologic and pathophysiological
conditions will be discussed, with emphasis on the molecular
mechanisms and catalytic and non-catalytic implications of
enzyme compartmentalization.
2. The recognition of a LT biosynthetic metabolon at the
nuclear envelope
The ¢rst decade of research into LT biosynthesis was dom-
inated by e¡orts to characterize the relevant enzymes, their
cofactors, and their cellular distribution. Little was known
about the intracellular sites at which these enzymes func-
tioned. A foundation for our current understanding of such
matters derives from studies conducted in the late 1980s and
early 1990s, in which crude fractionation methods were used
to study the three key proteins involved in the initiation of LT
synthesis : cytosolic phospholipase A2 (cPLA2), 5-LO, and 5-
LO activating protein (FLAP). This work demonstrated that,
in both resting and activated cells, FLAP was con¢ned to a
particulate subcellular fraction, presumably a membrane site
[4]. By contrast, cPLA2 [5] and 5-LO [6] were found in the
soluble compartment of resting leukocytes, but were redistrib-
uted in a Ca2-dependent fashion to a particulate fraction
upon activation.
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Fig. 1. The 5-LO pathway of arachidonate metabolism leading to
the biosynthesis of LTs. HPETE, hydroperoxyeicosatetraenoic acid;
HETE, hydroxyeicosatetraenoic acid; oxo-ETE, oxo-eicosatetraenoic
acid; GSH, reduced glutathione; other abbreviations as de¢ned in
the text.
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It was inferred from these early studies that all three pro-
teins were co-localized at the same cellular membrane. More-
over, because LTs were recognized to be secreted from leuko-
cytes and to act as paracrine mediators, it was widely assumed
that the membrane site at which they were assembled was the
plasma membrane. However, none of these assumptions was
justi¢ed on the basis of the crude methods employed in these
initial studies.
In the early to mid-1990s, this issue was de¢nitively ad-
dressed by several laboratories in a series of studies that uti-
lized more comprehensive subcellular fractionation methods
as well as confocal and ultrastructural immunomicroscopic
techniques. Indeed, this body of work demonstrated co-local-
ization of all three proteins in activated leukocytes of various
types, including macrophages, monocytes, neutrophils, and
mast cells. Surprisingly, however, the site at which these pro-
teins were co-localized was not the plasma membrane, but the
nuclear envelope (see Fig. 2). FLAP, an arachidonic acid-
binding protein [7], was constitutively localized to the nuclear
envelope and perinuclear endoplasmic reticulum [8,9]. cPLA2
was found to translocate from its resting locale in the cytosol
to the nuclear envelope upon activation [9^12], and most ar-
achidonic acid released by the actions of cPLA2 was hydro-
lyzed from nuclear membrane phospholipids [12]. 5-LO was
likewise found to translocate to the nuclear envelope upon
activation [8,9,13^16]. It was subsequently discovered that
LTC4 synthase, like FLAP, is an integral nuclear envelope
protein [17]. Therefore, all the enzymatic steps involved in
LTC4 synthesis were localized to this membrane site.
A macromolecular complex of sequential enzymes in a met-
abolic pathway has been termed a ‘metabolon’ [18]. Such a
complex can be assumed to result in a cellular microenviron-
ment that allows e⁄cient channeling of metabolic intermedi-
ates. There may well be circumstances in which cPLA2 or 5-
LO translocate to and function at intracellular sites other than
the nuclear envelope, but it would be expected that deviations
from the above paradigm would compromise the metabolic
e⁄ciency of LT biosynthesis. An important implication of
the metabolon concept is that the site of macromolecular as-
sembly is not a random event, but has evolved in a manner
that serves the ‘wisdom’ of the cell. Given that LTs are known
to be secreted extracellularly, it is entirely counter-intuitive
that their synthesis occurs at the nuclear envelope. This fact
strongly suggests that they must subserve important functions
within or near the cell nucleus.
3. The complexity of 5-LO compartmentalization in resting
leukocytes
Further surprises regarding the localization of 5-LO, in
particular, were yet to come. First, the locale of 5-LO in
resting leukocytes was found to be cell-speci¢c. The protein
was exclusively cytosolic in resting peritoneal macrophages
[9], as well as monocytes [13], neutrophils [19], and eosinophils
[20,21] isolated from peripheral blood. By contrast, mast cells
[15,19] and alveolar macrophages [13,14] contained both cy-
tosolic and intranuclear pools of 5-LO. A constant feature in
all cell types was that LT biosynthesis was associated with the
translocation of 5-LO to the nuclear envelope. Of course, its
site of origin in the cytosol or the nucleoplasm of a resting cell
would dictate its eventual association with either the outer or
the inner nuclear membrane, respectively, upon activation.
The next surprise was that, even within a given cell type, 5-
LO was found to be capable of shuttling in or out of the
nucleus in response to in vivo or experimental conditions
(Fig. 2). Such movement is unassociated with enzyme activa-
tion and LT synthesis, and is to be distinguished from the
Ca2-dependent association with nuclear envelope that ac-
companies LT synthesis. This shuttling between compart-
ments is presumed to occur via the nuclear pore complex.
Examples of dynamic regulation of 5-LO compartmentaliza-
tion will be discussed later.
4. Molecular mechanisms mediating compartmentalization of
5-LO
Although we have learned a great deal about where 5-LO is
localized under di¡erent circumstances, our knowledge of the
molecular mechanisms which dictate localization is quite ru-
dimentary. It is highly likely that enzyme compartmentaliza-
tion is determined directly by interactions between speci¢c
molecular motifs within the protein and structural compo-
nents of the cell, or indirectly by interactions with intermedi-
ate partner proteins. Candidate motifs within 5-LO that may
mediate Ca2-dependent translocation to the nuclear envelope
include putative Ca2-binding and lipid-binding domains in
the N-terminal L-barrel region [22], a src homology-3 binding
domain near the C-terminus that may interact with cytoskel-
etal proteins [23], and one or more of the many consensus
sites for phosphorylation by various protein kinases, including
tyrosine kinases [24] and mitogen activated protein kinase
associated protein kinase [25]. By contrast, shuttling of 5-
LO through the nuclear pores of resting cells is almost cer-
tainly mediated by motifs functioning as nuclear import and
Fig. 2. Intracellular compartmentalization of steps involved in LT
biosynthesis. Gaps in the nuclear envelope represent nuclear pores.
Solid arrows and ¢lled arrowheads represent translocation of pro-
teins to the nuclear envelope. Dashed lines indicate shuttling of pro-
teins through nuclear pores. Solid lines with un¢lled arrowheads
represent the generation and £ow of metabolic intermediates. Pro-
cesses depicted between the brown lines are thought to represent
those occurring at the inner and/or outer membranes of the nuclear
envelope. Abbreviations as de¢ned in the text.
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export sequences that bind to chaperones capable of interact-
ing with the nuclear pore complex. Evidence supports a role
for a bipartite nuclear import sequence rich in basic residues
near the enzyme’s C-terminus [26], and several leucine-rich
motifs distributed throughout the protein might serve as can-
didate nuclear export sequences [27]. It is also likely that the
activities of such nuclear import and export sequences are
further regulated by phosphorylation reactions.
5. Dynamic regulation of 5-LO compartmentalization
The compartmentalization of 5-LO is subject to dynamic
modulation by such factors as culture conditions [20,28], cel-
lular recruitment to tissues [20,28,29], and cytokine exposure
[21]. Two examples of this dynamic regulation that have been
well studied are discussed for illustrative purposes. The ¢rst is
observed in the course of tissue-speci¢c macrophage di¡eren-
tiation. Monocytes circulating in peripheral blood are the pre-
cursors for all tissue macrophages. They emigrate from the
bloodstream, home to various tissues, and di¡erentiate in a
tissue-speci¢c fashion into mature tissue macrophages. Mono-
cytes themselves contain predominantly cytosolic 5-LO [13].
Interestingly, this cytosolic distribution is preserved during the
course of monocyte di¡erentiation into peritoneal macro-
phages [9] as well as pulmonary interstitial macrophages
[29]. However, the ¢nal stage of di¡erentiation into a pulmo-
nary alveolar macrophage, i.e. the process of macrophage
emigration through the alveolar wall and into the alveolar
space, is uniquely associated with import of 5-LO into the
nucleoplasm. This process appears to occur relatively quickly
upon cellular entry into the alveolar space, as a prominent
intranuclear pool of enzyme is found in virtually all alveolar
macrophages, regardless of their duration of residence in the
airspace [29]. This distribution of 5-LO in alveolar macro-
phages, apparently unique among mononuclear phagocytes,
may be a consequence of cellular exposure to the unique al-
veolar milieu. This conclusion is supported by the fact that 5-
LO distribution gradually reverts back to the monocyte/non-
alveolar macrophage pattern (i.e. predominantly cytosolic
pool) during removal of these cells from the alveolar compart-
ment and culture ex vivo over a period of 3 days [29]. This
reversal of 5-LO distribution pattern could re£ect either ex-
port of 5-LO molecules formerly found in the nucleoplasm, or
turnover of the intranuclear 5-LO and a failure to import into
the nucleus the newly synthesized polypeptide molecules. In
preliminary experiments, the nuclear export inhibitor lepto-
mycin failed to prevent this redistribution over time, suggest-
ing a failure of import in cells removed from the alveolus. On
the basis of these observations, we suggest that factors unique
to the alveolar milieu favor nuclear accumulation of 5-LO,
primarily by promoting nuclear import. The precise factors
and molecular mechanisms responsible for such import re-
main to be de¢ned.
A second example of dynamic regulation of 5-LO compart-
mentalization can be observed in eosinophils. Eosinophils iso-
lated from peripheral blood and studied in suspension contain
a predominant cytosolic pool of 5-LO. Upon adherence of
these cells on ¢bronectin, import of 5-LO into the nucleus
can be observed over a 30^60 min interval [20]. Such an intra-
nuclear pool of enzyme is also seen in eosinophils that adhere
to the vascular wall and emigrate from the bloodstream in the
process of recruitment to tissues [20].
6. E¡ects of 5-LO compartmentalization on LT synthetic
capacity
How do these shifts in intracellular distribution in£uence
the capacity for LT synthesis upon subsequent activation?
Interestingly, nuclear import of 5-LO increases LT synthetic
capacity in fully di¡erentiated alveolar macrophages, but re-
duces it in adherent eosinophils. These disparate consequences
of nuclear import in the two cell types can be attributed, at
least in part, to cell-speci¢c di¡erences in the capacities of
di¡erent enzyme pools to translocate to the nuclear envelope
in response to agonist stimulation. Thus, the intranuclear pool
of 5-LO in alveolar macrophages translocates readily to the
nuclear envelope, while the cytosolic pool does not [14]. In
contrast, the intranuclear pool of enzyme in adherent eosino-
phils translocates far less well upon stimulation than does the
cytosolic pool in eosinophils studied in suspension [20]. These
results reinforce the critical importance of enzyme transloca-
tion for 5-LO activation. A further contrast to both of these
situations is provided by the mast cell, in which both cytosolic
and intranuclear pools of 5-LO readily translocate to the nu-
clear envelope upon agonist activation [14]. The reasons for
cell- and compartment-speci¢c di¡erences in enzyme translo-
catability are not known at present, but likely re£ect di¡er-
ences in the distribution of critical protein kinases and/or of 5-
LO partners which act as anchors or chaperones. It should be
acknowledged that contrary results have been obtained with
eosinophils under di¡erent experimental circumstances. In
particular, incubation of eosinophils for 6 h with interleu-
kin-5 has been shown to increase intranuclear 5-LO as well
as LT synthetic capacity upon agonist stimulation; however,
translocation of enzyme following stimulation was not exam-
ined [21].
Another general means by which 5-LO localization may
in£uence the metabolic function of the enzyme involves its
capacity to interact with downstream enzymes. The major 5-
LO product of alveolar macrophages is LTB4. Synthesis of
this molecule requires the hydrolysis of 5-LO-derived LTA4
by the enzyme LTA4 hydrolase. Preliminary data derived
from both in situ (immunohistochemical staining of lung tis-
sue) and ex vivo (immuno£uorescence microscopy and sub-
cellular fractionation of isolated cells) studies indicate that in
alveolar macrophages, LTA4 hydrolase is found in both cyto-
solic and intranuclear compartments. In contrast, this enzyme
appears to be largely cytosolic in monocytes as well as in
structural lung cells such as epithelial cells. These data suggest
that nuclear import of the hydrolase accompanies that of 5-
LO which occurs during macrophage di¡erentiation in the
alveolar space (Fig. 2). The nuclear import of both enzymes
in parallel may facilitate e⁄cient coupling of these two se-
quential reactions at the nucleoplasmic face of the inner nu-
clear membrane of alveolar macrophages.
Finally, one can envision situations in which compartmen-
talization of this pivotal enzyme is altered in association with
disease states. This could occur on the basis of either inherited
or acquired alterations in any of the cellular components that
mediate its intracellular distribution, including molecular mo-
tifs within 5-LO itself, in signal transduction cascades, or in
partner proteins. Increases or decreases in LT biosynthetic
capacity could then occur as a result of such alterations, con-
tributing to disease expression.
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7. Consequences of the nuclear localization of 5-LO
It is now well accepted that, under most circumstances,
translocation of 5-LO to the nuclear envelope is a critical
component of enzyme activation. This process allows the en-
zyme to (1) gain access to substrate arachidonic acid which is
hydrolyzed from nuclear membrane phospholipids and pre-
sented by FLAP, and (2) couple with downstream enzymes
necessary for LT synthesis. The surprising observation that
the LT biosynthetic metabolon is found at the nuclear enve-
lope, rather than other membrane sites, surely suggests that
LTs or alternative metabolic byproducts such as reactive oxy-
gen species possess important paracrine actions in or near the
nucleus. An important goal of future research will be to iden-
tify the nuclear targets for the actions of 5-LO products.
There is precedent for nuclear eicosanoid receptors [30^32],
and the types and roles of such receptors mediating direct
intranuclear actions of 5-LO metabolites remain to be eluci-
dated.
In addition, it is becoming increasingly apparent that cells
have evolved elaborate mechanisms to be able to dynamically
regulate the distribution of 5-LO between cytosol and nucle-
oplasm of resting cells. There is evidence that this represents
one means for modulating the output of the LT biosynthetic
pathway. Future studies must elucidate how compartmental-
ization in£uences the ability of 5-LO to translocate upon ac-
tivation and to couple with upstream and downstream com-
ponents of the metabolon. It is also appealing to speculate
that 5-LO might subserve functions beyond its traditional
catalytic role. The rationale for this possibility derives from
the fact that the enzyme is capable of interacting with other
molecules [23,33], and from the observations that even in rest-
ing cells not synthesizing LTs, it has been identi¢ed in both
the euchromatin region of the nucleus (where active gene tran-
scription occurs) [13] and tightly associated with chromatin
[19]. The latter ¢ndings suggest the intriguing possibility
that 5-LO might regulate transcriptional events in the nucleus.
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